ClinicalTrials.gov
public full text
Public Domain
Manipulating the Peri-Infarct Area Using Maraviroc to Enhance Motor Skills After Stroke
MASTER is a single-center, patient and investigator-blinded, Randomized Controlled Trial (RCT) to compare the efficacy of Maraviroc, a C-C chemokine receptor 5 (CCR5) antagonist, against placebo regarding motor function and motor learning skills in the first 3 months after ischemic stroke.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of Maraviroc in Post-stroke Cognitive Impairment#861831
- Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke#860152
- Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis#6892
- Clopidogrel Versus Cilostazol in Ischemic Stroke#1172288
- Argatroban Plus r-tPA for Posterior Circulation Infarction（AR-PCI）#916966
Record · ID 830709
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive